Ramesh Ummanni

8PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsBiologically active moleculesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2025
Valosin-Containing Protein (VCP/p97) Mediates Neuroendocrine Differentiation in Prostate Cancer Cells Through Pim1 Signaling Inducing Autophagy.

K K Sruthi, Ramesh Ummanni

|Oct 29, 2024
Proteomic Analysis of Microsomal Proteins Reveals That MVP Is Crucial for the Secretion of GDF-15, Which in Turn Promotes the Neuroendocrine Differentiation of PCa Cells.

Sandhya Venkata Lakshmi Pampana, Biswajit Biswas, Saikiran Jajula

|Apr 11, 2023
AMPK targets a proto-oncogene TPD52 (isoform 3) expression and its interaction with LKB1 suppress AMPK-GSK3β signaling axis in prostate cancer.

Priyanka Khilar, K K Sruthi, Sakkarai Mohamed Asha Parveen

|Aug 14, 2019
N-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expression.

Subrata K Pore, Anirban Ganguly, Samaresh Sau

|Jan 24, 2019
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.

Karthik Reddy Kami Reddy, Chandrashekhar Dasari, Shalini Vandavasi

|Apr 26, 2018
Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.

Divya Duscharla, Karthik Reddy Kami Reddy, Chandrashekhar Dasari

Pageof 2

Frequent Collaborators

1 joint publications

Subrata K Pore